LISA HOHL: Open Payments
NPI 1235373705 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 50 payments from 16 companies in 2025. Trend: 2023 $901 · 2024 $957 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $131 |
| Merck Sharp & Dohme LLC | 5 | $121 |
| Novo Nordisk Inc | 6 | $110 |
| Amgen Inc. | 5 | $97 |
| ABBVIE INC. | 5 | $97 |
| Lilly USA, LLC | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Abbott Laboratories | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
Products named: GARDASIL 9, Ozempic, MOUNJARO, EVENITY, FREESTYLE LIBRE 3, VOQUEZNA, XIFAXAN, LAGEVRIO.
Industry payments across DE — which companies pay providers there.
